Milestone Pharmaceuticals Inc (MIST)
Milestone Pharmaceuticals Market Cap: 92.67M for May 23, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 22, 2024 | 93.21M |
May 21, 2024 | 91.61M |
May 20, 2024 | 92.94M |
May 17, 2024 | 92.67M |
May 16, 2024 | 93.21M |
May 15, 2024 | 92.14M |
May 14, 2024 | 91.61M |
May 13, 2024 | 90.54M |
May 10, 2024 | 90.52M |
May 09, 2024 | 90.52M |
May 08, 2024 | 90.52M |
May 07, 2024 | 92.65M |
May 06, 2024 | 92.65M |
May 03, 2024 | 89.98M |
May 02, 2024 | 87.32M |
May 01, 2024 | 85.19M |
April 30, 2024 | 87.85M |
April 29, 2024 | 83.60M |
April 26, 2024 | 82.00M |
April 25, 2024 | 84.13M |
April 24, 2024 | 88.39M |
April 23, 2024 | 90.52M |
April 22, 2024 | 86.79M |
April 19, 2024 | 87.32M |
April 18, 2024 | 86.79M |
Date | Value |
---|---|
April 17, 2024 | 93.18M |
April 16, 2024 | 93.71M |
April 15, 2024 | 93.45M |
April 12, 2024 | 92.11M |
April 11, 2024 | 90.25M |
April 10, 2024 | 88.92M |
April 09, 2024 | 88.92M |
April 08, 2024 | 96.91M |
April 05, 2024 | 95.84M |
April 04, 2024 | 93.18M |
April 03, 2024 | 93.71M |
April 02, 2024 | 95.84M |
April 01, 2024 | 97.44M |
March 28, 2024 | 95.14M |
March 27, 2024 | 95.67M |
March 26, 2024 | 96.20M |
March 25, 2024 | 91.95M |
March 22, 2024 | 92.48M |
March 21, 2024 | 82.91M |
March 20, 2024 | 79.72M |
March 19, 2024 | 77.07M |
March 18, 2024 | 79.19M |
March 15, 2024 | 77.07M |
March 14, 2024 | 75.47M |
March 13, 2024 | 77.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Acasti Pharma Inc | 25.00M |
Aurinia Pharmaceuticals Inc | 750.14M |
Edesa Biotech Inc | 13.86M |
Lexaria Bioscience Corp | 36.85M |
Xenon Pharmaceuticals Inc | 2.898B |
Market Cap Related Metrics
PEG Ratio | -0.0387 |
Price to Book Value | 2.321 |
Price | 1.74 |
Earnings Yield | -71.84% |
PEGY Ratio | -0.0387 |